Rabies Immunoglobulin Administration for Penile Exposures
Equine rabies immune globulin should NOT be applied to the shaft of the penis; instead, it should be thoroughly infiltrated around and into the wound site only, with any remaining volume injected intramuscularly at a site distant from vaccine administration.
Proper Administration of Rabies Immunoglobulin
- For post-exposure prophylaxis, rabies immunoglobulin (whether human or equine) should be infiltrated thoroughly in the area around and into the wounds, if anatomically feasible 1, 2
- Any remaining volume should be injected intramuscularly at a site distant from vaccine administration 1, 2
- The recommended dose is 20 IU/kg body weight for both human and equine rabies immunoglobulin 1, 2
- This administration technique is critical as rare failures of post-exposure prophylaxis have occurred when smaller amounts of rabies immunoglobulin were infiltrated at exposure sites 1, 2
Specific Considerations for Penile Exposures
- For penile wounds, the same principles apply - the immunoglobulin should be infiltrated around and into the actual wound site only, not applied generally to the shaft of the penis 1
- Proper wound cleansing with soap and water and a virucidal agent is an essential first step before immunoglobulin administration 2
- The full dose should never be applied indiscriminately to anatomical areas not directly involved in the exposure 1
Important Precautions
- Rabies immunoglobulin should never be administered in the same syringe or at the same anatomical site as the vaccine 1, 2
- Equine rabies immunoglobulin (ERIG) carries a higher risk of adverse reactions compared to human rabies immunoglobulin (HRIG) 1
- Potential adverse reactions to ERIG include:
Administration Timeline
- Rabies immunoglobulin should be administered only once at the beginning of post-exposure prophylaxis 1, 2
- If not given when vaccination was begun, it can still be administered through the seventh day after the first vaccine dose 1, 2
- Beyond the seventh day, rabies immunoglobulin is not indicated as an antibody response to the vaccine is presumed to have occurred 1, 2
Clinical Pearls and Pitfalls
- A common pitfall is applying immunoglobulin to unaffected areas rather than concentrating it at the wound site 1
- Failures in post-exposure prophylaxis have occurred when:
- In developing countries where HRIG might not be available, purified ERIG has been used effectively with a relatively low incidence of adverse reactions (0.8%-6.0%) 1, 6